Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder
SPRB Stock | USD 0.38 0.01 2.70% |
About 54% of Spruce Biosciences' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Spruce Biosciences suggests that some traders are interested. The current market sentiment, together with Spruce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Spruce Biosciences stock news signals to limit their universe of possible portfolio assets.
Spruce |
Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies f
Read at businesswire.com
Spruce Biosciences Fundamental Analysis
We analyze Spruce Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spruce Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spruce Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Spruce Biosciences is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Spruce Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spruce Biosciences stock to make a market-neutral strategy. Peer analysis of Spruce Biosciences could also be used in its relative valuation, which is a method of valuing Spruce Biosciences by comparing valuation metrics with similar companies.
Peers
Spruce Biosciences Related Equities
INZY | Inozyme Pharma | 6.82 | ||||
HOOK | Hookipa Pharma | 6.37 | ||||
DAWN | Day One | 1.05 | ||||
ELDN | Eledon Pharmaceuticals | 0.95 | ||||
ABOS | Acumen Pharmaceuticals | 1.14 | ||||
TERN | Terns Pharmaceuticals | 3.02 | ||||
XFOR | X4 Pharmaceuticals | 7.69 |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |